BoneHealthResource_logo
Hamburger Iconhamburger_white
  • OSTEOPOROSIS & BONE HEALTH
  • POST-FRACTURE CARE
  • TOOLS FOR A SUCCESSFUL PFC PROGRAM
  • RESOURCES
  • ABOUT US

INTENDED FOR US HEALTHCARE PROFESSIONALS

UNDERSTANDING THE GAP IN POST-FRACTURE CARE

Osteoporosis is a chronic disease, and breaking a bone can be a life-altering event1,2

About 54 million

Americans have osteoporosis and low bone mass3

About 54

million Americans have osteoporosis and low bone mass3

1 in 2 women
over the age of 50 will experience a fracture related to osteoporosis in their remaining lifetime3,4

84%

of women with postmenopausal osteoporosis who experienced a fracture were not treated for the underlying disease of osteoporosis within 6 months, according to a survey of an integrated healthcare delivery system in Washington State5,*

*Survey conducted by Group Health Cooperative that provides comprehensive healthcare to ~ 600,000 individuals in Washington State.

Data based on women aged 55 and older who experienced an osteoporosis-related fracture from January 1, 2013, to March 30, 2014.

How Does Osteoporosis Impact the Healthcare System?

A Case for Change

Osteoporosis is a common disease.3 In a year, osteoporosis-related fractures in the United States led to:4,*

hospital_admissions> 500,000 hospital admissions
medical_office_visits~ 2.6 million medical office visits
nursing_home_admissions~ 180,000 nursing home admissions
  • Following an initial osteoporosis-related fracture, postmenopausal women are 5 times more likely to fracture again within a year6,†
  • Subsequent fractures are associated with a 2- to 3-fold increase in medical costs compared to an initial fracture7,‡
  • The total annual expense of osteoporosis-related fracture care totaled $57 billion in 2018 and is projected to increase to $95.2 billion in 20408,§
Establishing a coordinated-care model has shown to be cost effective and an efficient interdisciplinary case management approach.9 It can improve the outcomes of patients with osteoporosis-related fractures and help prevent subsequent fractures10
Click here to learn more

*Data from Bone Health & Osteoporosis: A Report of the Surgeon General, published in 2004.

†Data represent a population-based study of 4,140 postmenopausal women aged 50-80 years.

‡Data based on a retrospective claim-based study, which assessed 1-year medical costs associated with second fracture(s) for patients over 50 years old with an initial closed hip, clinical vertebral, or nonhip nonvertebral fracture using 2002-2008 MarketScan® Commercial Claims and Encounters and Medicare Supplemental and Coordination of Benefits databases.

§Estimates based on microsimulation forecasting model to project annual incidence and costs in women aged > 65 years. Validated Fracture Risk Assessment Tool (FRAX™) tables and insights from the National Health and Nutrition Examination Survey (NHANES) were used to estimate the future burden among Medicare-eligible women. Direct costs following a fracture were based on a claims analysis, differed by category (eg, inpatient, outpatient, emergency department, long-term care, pharmacy costs following a fracture, and other), and differed for individuals experiencing a single fracture within a year versus those with a subsequent fracture. Indirect societal costs related to productivity losses and informal caregiving were included in calculating the total annual cost.

The 2020 AACE/ACE Osteoporosis Guidelines Recommends All Postmenopausal Women ≥ 50 Years Should Be Evaluated for Osteoporosis Risk11

An osteoporosis diagnosis is made when a patient presents with:11

  1. T-score -2.5 or below in the lumbar spine, femoral neck, total proximal femur, or 1/3 radius
  2. Low-trauma spine or hip fracture (regardless of bone mineral density)
  3. T-score between -1.0 and -2.5 and a fragility fracture of proximal humerus, pelvis, or distal forearm
  4. T-score between -1.0 and -2.5 and high FRAX™ (or if available, TBS-adjusted FRAX™) fracture probability based on country-specific threshold

When the initial diagnosis of osteoporosis is made based on a T-score of -2.5 or below, the diagnosis persists even when a subsequent DXA measurement shows a T-score better than -2.5.11

Therapy Considerations

The AACE/ACE Osteoporosis Guidelines stratify patients as high risk for fracture or very high risk for fracture to help determine initial treatment choice and duration.11 Bone builders and certain antiresorptives should be considered as initial therapy options for patients at very high risk for fracture.11 Patients are considered to be at very high risk for fracture if they have any of the following risk factors:11

recent_fractureRecent fracture (e.g., within the last 12 months)
Fractures_on_osteoporosisFractures while on approved osteoporosis therapy
Multiple_fracturesMultiple fractures
Fractures_on_drugsFractures while on drugs that may cause skeletal harm
very_low_tscoreVery low T-score (e.g., < -3.0), OR very high fracture probability by FRAX™ (e.g., major osteoporotic fracture > 30%, hip fracture > 4.5%)
High_fall_riskHigh fall risk or history of injurious falls

Upon discontinuation of a bone builder, it is recommended to use an antiresorptive to prevent bone density decline and loss of fracture efficacy.11

Guidelines provide recommendations for treating osteoporosis and reducing the risk of osteoporosis-related fractures11

References: 1. Cosman F, de Beur SJ, LeBoff MS, et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25:2359-2381. 2. National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2014. 3. Bone Health & Osteoporosis Foundation website. What is osteoporosis and what causes it? Accessed February 15, 2022. https://www.bonehealthandosteoporosis.org/patients/what-is-osteoporosis/. 4. U.S. Department of Health and Human Services. Bone Health & Osteoporosis: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General, 2004. 5. Boudreau DM, Yu O, Balasubramanian A, et al. A survey of women’s awareness of and reasons for lack of postfracture osteoporotic care. JAGS. 2017;65:1829-1835. 6. van Geel TACM, van Helden S, Geusens PP, Winkens B, Dinant G-J. Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis. 2009;68:99-102. 7. Song X, Shi N, Badamgarav E, et al. Cost burden of second fracture in the US health system. Bone. 2011;48:828-836. 8. Lewiecki EM, Ortendahl JD, Vanderpuye-Orgle J, et al. Healthcare policy changes in osteoporosis can improve outcomes and reduce costs in the United States. JBMR Plus. 2019;3:1-7. 9. Curtis JC, Silverman SL. Commentary: The five Ws of a fracture liaison service: why, who, what, where and how? In osteoporosis, we reap what we sow. Curr Osteoporos Rep. 2013;11. doi:10.1007/s11914-013-0177-9. 10. Wu C-H, Tu S-T, Chang Y-F, et al. Fracture liaison services improve outcomes of patients with osteoporosis related fractures: a systematic literature review and meta-analysis. Bone. 2018;111:92-100. 11. Camacho PM, Petak S, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update. Endocr Pract. 2020;26(suppl 1):1-46.

PLEASE VERIFY THAT YOU ARE A HEALTHCARE PROFESSIONAL

Yes

I verify and want to continue

No

I am not a healthcare professional

  • OSTEOPOROSIS & BONE HEALTH
  • POST-FRACTURE CARE
  • TOOLS FOR A SUCCESSFUL PFC PROGRAM
  • RESOURCES
  • ABOUT US
Amgen_Ucb_logo
  • Resources
  • Contact Us
  • Terms of Use
  • Privacy Statement
  • Your Cookie Preferences

© 2022 Amgen Inc. All rights reserved.

Footer_logo